Clinical trials
Completed Hyperlipidemias trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Amgen | 3 |
| Takeda | 3 |
| 89bio, Inc. | 1 |
| AstraZeneca | 1 |
| Esperion Therapeutics, Inc. | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Medical University of Silesia | 1 |
| Poznan University of Medical Sciences | 1 |
| Solvay Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 18 |
| Hypercholesterolemia | 5 |
| Dyslipidemias | 4 |
| Metabolic Diseases | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertriglyceridemia | 2 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Syndrome | 2 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.